P0128COMPARISON OF ULTRASTRUCTURE FEATURES BETWEEN PATIENTS WITH MERCURY-ASSOCIATED MEMBRANOUS NEPHROPATHY AND IDIOPATHIC MEMBRANOUS NEPHROPATHY

Abstract Background and Aims Prolonged exposure to mercury can cause membranous nephropathy. The routine clinicopathological features of mercury-associated membranous nephropathy (M-MN) and idiopathic membranous nephropathy (I-MN) are similar. The difference in ultrastructure between them was observ...

Full description

Saved in:
Bibliographic Details
Published inNephrology, dialysis, transplantation Vol. 35; no. Supplement_3
Main Authors Qin, Aibo, Lin, Zishan, Zhou, Fude, Zhao, Minghui, Wang, Suxia, Cui, Zhao
Format Journal Article
LanguageEnglish
Published Oxford University Press 01.06.2020
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Background and Aims Prolonged exposure to mercury can cause membranous nephropathy. The routine clinicopathological features of mercury-associated membranous nephropathy (M-MN) and idiopathic membranous nephropathy (I-MN) are similar. The difference in ultrastructure between them was observed clinically. The current study retrospectively compared the ultrastructure features, clinical and pathological data, treatment and prognosis of patients with M-MN and I-MN. Method Thirteen patients with M-MN and 13 patients with I-MN were enrolled. The clinical and pathological data were retrospectively collected. Electron micrographs of glomerular capillaries were taken and the foot process width (FPW) and the number of foot processes per 10 μm glomerular basement membrane (GBM) were measured. The presence and location of electron-dense deposits in mesangium and subendothelial region were recorded. Results Patients with M-MN were younger (38.7±8.5 versus 45.8±5.7 years, P=0.020), with a shorter duration of complete remission (9.0±6.1 versus 20.3±9.8 months, P=0.004) and lower relapse rate (0% versus 45.5%, P=0.014) than patients with I-MN. As to ultrastructure, patients with M-MN had lower levels of FPW [974.3nm (range 791.2∼1504.4) versus 2370.6nm (range 2219.4∼2559.1), P=0.001, Figure 1], more foot processes per 10 μm GBM [8.1 (range 5.2∼10.0) versus 3.3 (range 3.1∼3.5), P=0.001], and higher ratio of mesangial electron-dense deposits (41.7% versus 0, P=0.015, Figure 2) than those with I-MN. Multivariate analysis showed that type of disease (M-MN or I-MN) and stage of MN (stageIor stageIIand above) were the two only determinants of FPW. FPW over 1645 nm differentiated M-MN from I-MN with high sensitivity (92.3%) and specificity (83.3%). Conclusion The quantitative analysis of foot processes may offer a potential tool to distinguish M-MN from I-MN. Better prognosis in patients with M-MN may be related to minor podocyte damage. Figure 1. Foot process width of patients with M-MN, I-MN, M-MN in stage I, I-MN in stage I and normal control. Data expressed as median with range [interquartile range (IQR)]. Figure 2. Electron microscopy (original magnification ×10000). (A) Normal control. The foot processes were separate. (B) Example of M-MN. Extensive effacement of foot processes with a large amount of electron-dense deposits diffusely located in the subepithelial region. (C) Example of M-MN. Partial effacement of foot process and partially location of electron-dense deposits. The arrow on the left indicate the separate foot processes and there was no electron-dense deposits. The arrow on the right indicate the extensive effacement of foot processes and electron-dense deposits located in the subepithelial region. (D) Example of M-MN. A small amount of electron-dense deposits in the mesangial region (arrow). M-MN: mercury-associated membranous nephropathy
ISSN:0931-0509
1460-2385
DOI:10.1093/ndt/gfaa142.P0128